XML 107 R93.htm IDEA: XBRL DOCUMENT v3.22.0.1
Payroll costs, share based payments and management incentive schemes - Director and Senior Management Share Awards Narrative (Details)
€ in Millions
1 Months Ended 12 Months Ended
Feb. 28, 2021
shares
Jan. 31, 2021
shares
Sep. 30, 2020
shares
Feb. 29, 2020
shares
Jan. 31, 2020
shares
Sep. 30, 2019
shares
Jan. 31, 2019
shares
Dec. 31, 2021
EUR (€)
shares
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
EUR (€)
Dec. 31, 2021
shares
$ / shares
Feb. 01, 2021
$ / shares
Jan. 30, 2021
$ / shares
Jan. 01, 2021
$ / shares
Dec. 31, 2020
shares
$ / shares
Sep. 01, 2020
$ / shares
Aug. 01, 2020
$ / shares
Feb. 01, 2020
$ / shares
Jan. 01, 2020
$ / shares
EBITDA                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               3 years                      
Vesting period               3 years                      
Share price performance                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               3 years                      
Vesting period               3 years                      
Cumulative net sales                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               3 years                      
Vesting period               3 years                      
Ordinary shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Share price (in Dollars per share) | $ / shares                     $ 24.50   $ 25.29   $ 21.04   $ 25.50    
Management Award 2018 | EBITDA                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               4 years                      
Vesting period               4 years                      
Management Award 2018 | Share price performance                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               3 years   2 years                  
Vesting period               3 years   2 years                  
Management Award 2018 | Share price performance | Bottom of range                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               2 years                      
Vesting period               2 years                      
Management Award 2018 | Share price performance | Top of range                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Vesting period               5 years                      
Vesting period               5 years                      
Restricted Shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments outstanding in share-based payment arrangement (in shares)                     2,016,855       3,178,400        
New awards granted in the period               820,202                      
Number of equity instruments exercised (in shares)               1,861,826                      
Restricted Shares | Key management personnel                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Expense from share-based payment transactions with employees | €               € 4.3 € 8.3 € 14.0                  
Restricted Shares | Management Award 2017                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments exercised (in shares) 451,719 368,154         85,315                        
Reclassification of awards for settlement of tax liabilities 180,268 150,926         33,383                        
Share price (in Dollars per share) | $ / shares                       $ 25.89   $ 25.42          
Restricted Shares | Management Award 2017 | Ordinary shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments exercised (in shares) 271,451 217,228         51,932                        
Restricted Shares | Management Award 2016                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments exercised (in shares)   1,041,953   1,626,006 284,555                            
Reclassification of awards for settlement of tax liabilities   454,320   697,964 120,739                            
Share price (in Dollars per share) | $ / shares                           $ 25.42       $ 19.53 $ 22.37
Restricted Shares | Management Award 2016 | Ordinary shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments exercised (in shares)   587,633   928,042 163,816                            
Restricted Shares | Management Award 2018                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments exercised (in shares)     42,825                                
Reclassification of awards for settlement of tax liabilities     17,170                                
Share price (in Dollars per share) | $ / shares                               $ 25.30      
Restricted Shares | Management Award 2018 | Ordinary shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments exercised (in shares)     25,655                                
January 1, 2016 | Restricted Shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments outstanding in share-based payment arrangement (in shares)                     0       1,041,953        
New awards granted in the period               0                      
Number of equity instruments exercised (in shares)               1,041,953                      
January 1, 2017 | Restricted Shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments outstanding in share-based payment arrangement (in shares)                     0       819,873        
New awards granted in the period               0                      
Number of equity instruments exercised (in shares)               819,873                      
January 1, 2019 | Restricted Shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments outstanding in share-based payment arrangement (in shares)                     152,695       159,561        
New awards granted in the period           166,427   0                      
Number of equity instruments exercised (in shares)               0                      
January 1, 2020 | Restricted Shares                                      
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                                      
Number of equity instruments outstanding in share-based payment arrangement (in shares)                     645,093       710,438        
New awards granted in the period         761,979     0                      
Number of equity instruments exercised (in shares)               0